METRNL and obesity disorder: This finding is somewhat unexpected, as METRNL, previously considered mostly an adipokine and myokine, has been proposed to play a protective role against insulin resistance and inflammation in experimental models of obesity (43), and is usually downregulated in adult patients with obesity (44).